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Toxin–antitoxin (TA) systems are present in many bacteria
and play important roles in bacterial growth, physiology, and
pathogenicity. Those that are best studied are the type II TA
systems, in which both toxins and antitoxins are proteins. The
HicAB system is one of the prototypic TA systems, found in
many bacterial species. Complex interactions between the pro-
tein toxin (HicA), the protein antitoxin (HicB), and the DNA
upstream of the encoding genes regulate the activity of this sys-
tem, but few structural details are available about how HicA
destabilizes the HicB–DNA complex. Here, we determined the
X-ray structures ofHicB and theHicABcomplex to 1.8 and2.5 A˚
resolution, respectively, and characterized their DNA interac-
tions. This revealed that HicB forms a tetramer and HicA and
HicB form a heterooctameric complex that involves structural
reorganization of the C-terminal (DNA-binding) region of
HicB. Our observations indicated that HicA has a profound
impact onbindingofHicB toDNAsequences upstreamofhicAB
in a stoichiometric-dependent way. At low ratios of HicA:HicB,
there was no effect on DNA binding, but at higher ratios, the
affinity for DNA declined cooperatively, driving dissociation of
the HicA:HicB:DNA complex. These results reveal the struc-
tural mechanisms by which HicA de-represses the HicB–DNA
complex.
Toxin–antitoxin (TA)3 systems are found in a wide range of
bacteria, and the best studied are the type II TA systems, where
both the toxins and the antitoxins are proteins. Type II TA
systems are structurally and functionally diverse, with 14 sepa-
rate families classified by either three-dimensional structure or
mode of action (see Refs. 1–3 for recent reviews). The operons
for these systems are typically organized so that the antitoxin
precedes the toxin encoding gene. Although the functions of
TA systems are not fully clarified, they are known to play roles
in postsegregational killing and abortive infection (cell death prior
to bacteriophage replication). They have also been proposed to
play roles in the formation of metabolically quiescent persister
cells, which can survive exposure to otherwise supra-lethal doses
of antibiotic, and subsequently grow when the antibiotics are
removed (1, 4–6). However, the evidence for a role of TA systems
in persister cell formation is controversial (7–9).
Different toxins have different molecular targets in the cell
and are able to modify functions such as transcription, transla-
tion, or DNA replication (2, 10, 11), leading to growth arrest.
The action of the toxin can be blocked after binding by the
cognate antitoxin (1, 12). Protein antitoxins characterized to
date consist typically of two recognition sites, one involved in
toxin binding and the other in DNA binding. Monomeric and
multimeric forms of both toxins and antitoxins can exist in
solution and higher order complexes have been reported
(2, 12).
A range of factors determine the relative levels of toxin and
antitoxin in the cell. Compared with toxins, antitoxins are gen-
erally sensitive to degradation by proteases, including Clp and
Lon (13, 14). In addition, there are interactions between the
promoter region of the TA operon and the antitoxin or the
toxin–antitoxin complex that regulates transcription. These
interactions differ depending on the TA system (1, 15).
A prototypic model, describing regulation of the operon,
indicates that antitoxin alone binds weakly to the promoter
region. However, introduction of the toxin can modify the
DNA-binding affinity of the antitoxin in a concentration-de-
pendent fashion (15, 16). At low toxin:antitoxin ratios, binding
is enhanced (17–26). At high toxin:antitoxin ratios the toxin
acts as a de-repressor and DNA-binding affinity is reduced (15,
20, 22, 27, 28). This phenomenon of TA transcription being
regulated by the toxin acting as either a co- or de-repressor is
referred to as conditional cooperativity (2, 16). Aside from
DinJ–YafQ (29) and MqsRA (30), the majority of TA systems
are believed to display conditional cooperativity.
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TheHicAB system iswidely distributed in a range of bacteria,
and there is evidence that the toxins are RNases (31–33). We
have previously studied the HicAB system in Burkholderia
pseudomallei, a pathogen found in tropical regions of the world
(34) which frequently causes chronic or latent infections of
humans (35). The B. pseudomalleiHicAB system plays a role in
regulating the frequency of persister cells and may therefore
play a role in disease (36). Recently, a truncated version of the
HicAB complex from a different bacterium, Yersinia pestis, was
solved by X-ray crystallography, and biochemical studies pro-
vided direct evidence of HicA3 acting as anmRNase andHicB3
as a autoregulatory DNA binder (33). The HicAB system from
Escherichia coli has also been studied, and an excess of HicA
shown to de-repress a HicB–DNA complex and restore tran-
scription of HicB (37).
The X-ray structures of complexes representing many TA
classes have been solved but to date there have been few exam-
ples of complexes representing the fully de-repressed state (15,
38). In particular, an atomic level description of how HicA
destabilizes the HicB–DNA repressor complex has not been
reported. Here we report the X-ray structures of the B. pseu-
domallei HicB and the HicAB complex and the characteriza-
tion of their DNA interactions. Together these results reveal
the structural mechanisms by which HicA de-represses the
HicB–DNA complex.
Results
Structure determination of HicB
Purified HicB (sequence in Fig. 1A; Table S1) formed a
tetramer (Fig. S1) and yielded crystals that diffracted to 1.8 Å
(Table S2). Crystals of a mutant of HicB with two methionine
substitutions (HicB-I51M/I99M) (33) incorporating selenome-
thionine, diffracted to 3 Å which yielded a partial model. To
assist in finding amolecular replacement (MR) solution,we also
purified a HicB N-terminal domain (N-domain) construct
(HicB-NT, residues 1–86 lacking the C-terminal domain
(C-domain)) (Fig. S2) and crystals diffracted to 1.5 Å. Using a
combination of these datasets the complete structure of HicB
was solved by molecular replacement and exists as a tetramer
(Fig. 1B and Table S3). Each subunit consists of the N-domain
(Met-1–Leu-85), a linker region (Ser-86–Glu-93) and a C-do-
main (Arg-94–Lys-135) (Fig. 1C). The N-domain adopts an
antiparallel 1231234 fold (Fig. S2) where the central
helix 1 (Ile-32–Leu-53) lies within a cleft formed by 123
strands. The C-domain adopts a ribbon-helix-helix (RHH)
(556)motif that forms a strand-swapped dimerwith a part-
ner C-domain. This occurs at two sites between subunits 1/3
and 2/4, forming two intact RHH domains (Fig. 1B). The
tetramer has a single 2-fold symmetrical axis with dimerization
interfaces between adjacentN- andC-domains. The subunits of
Figure 1. Crystal structure of HicB. A, sequence of B. pseudomallei HicB and comparison to the closest structural homologue, HicB3 from Y. pestis. Symbols
indicate a conserved residue (*), conservative mutation (:), and a semi-conservative mutation (.). Underlined C-terminal residues were deleted in the His6-
tagged construct of HicB used in this study. B, the tetrameric crystal structure of HicB with subunits highlighted and dimerization interfaces at both the
N-terminal and C-terminal across adjacent subunits. C, single subunit of HicB with secondary structure elements labeled.D, HicB tetramer with the C-terminal
domains rendered with a solid surface and residues at the interfaces between C-terminal pairs are annotated.
Structure of HicAB
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HicB can adopt one of two different configurations where the
N-domain 1 helices are either sequestered and lie parallel to
the C-domains (subunits 1 and 4) or are solvent exposed and
orient perpendicularly to the C-domains (subunits 2 and 3)
(Fig. 1D and Fig. S3, A and B). This nonsymmetrical arrange-
ment leads to two distinct sets of hydrophobic and electrostatic
interactions between the N- and C-domains (Fig. S3C). N-do-
mains of subunits 1 and 4 interact with the C-domains of sub-
units 2 and 3, respectively, via principally electrostatic interac-
tions, whereas the reverse set of interactions (e.g. N-domain of
subunit 2 with C-domain of subunit 4) employ predominantly
hydrophobic interactions. The interface between adjacent
RHH domains is comprised of only alanine residues 109 and
112 and histidine 115 that also provide little interaction. This
arrangement creates two dimeric C-domains that interactmin-
imally with each other and the N-domains (Fig. 1D).
HicA binding drives conformational rearrangement from a
closed to an open form of HicB
A HicAB complex (Fig. S4) was prepared and crystals dif-
fracted to 2.5 Å from which the structure was solved via MR
(Table S3). The asymmetrical unit of the HicAB complex con-
tains four HicA and four HicB protomers arranged as a 222
symmetrical heterooctamer (Fig. 2A) with four identical HicA
interaction sites at the N-domains of HicB. The positively
charged face of the-sheet of HicA binds to the1 helix and3
strand of HicB (Fig. 2B). In the complex, the dsRNA-binding
domain-like fold of the HicA monomer is retained. However,
the 1-2 loop, which includes the functionally important res-
idues Gly-22 andHis-24 in theWTHicA, is buried and projects
toward a polar pocket on HicB formed by Ser-27, Asn-38, and
Phe-41 (Fig. 2C). A complete list of interactions between the
two proteins is given in Table S4.
The conversion of the HicB tetramer to the higher symmetry
HicAB heterooctamer requires extensive conformational rear-
rangements that generate a more open conformation (Fig. 2A).
These conformational rearrangements are most marked for
subunits 1 (blue) and 4 (yellow) of HicB that undergo a domain
rearrangement to flip the 1 helix from a sequestered confor-
mation into an exposed conformation that can bindHicA. Con-
versely, helix 1 which is already partially solvent exposed in
subunits 2 (pink) and 3 (green) of HicB undergoes a smaller 2.4
Å lateral displacement (Fig. 3A).
The displacement of the1 helix in subunits 1 and 4 requires
a reshuffling of packing interactions within the N-domains and
the interface to the C-domain (Fig. 2D). For example, the elec-
trostatic interactions that tethered the N-domain of subunit 1
to the C-domain of subunit 2 (Fig. S3C) are lost. These are
replaced by a hydrophobic network between N-domain resi-
dues Ile-51, Val-57, Phe-59, and Pro-92 and Pro-100/Phe-102
of an intersubunit C-domain (Fig. 2D). Supplementary ionic
interactions between adjacent subunits, e.g. Glu-58–Lys-106
form additional intersubunit interactions to stabilize the sym-
metrical conformation of HicB. In the complex, Leu-85 rotates
60°, breaking the tethering interaction to theC-domains of sub-
unit 1 and 4 (Pro-100 and Phe-102) that were present in free
HicB (Fig. S3C). Leu-85 is instead drawn into an intrasubunit
hydrophobic network (Ile-22, Ile-43, Val-47, Val-57, and Val-
83) with the N-domain (Fig. 2D) which stabilizes the open con-
formation. Similarly, Leu-88 rotates into an empty pocket cre-
ated by the 2.8 Å shift of Glu-48 that now forms a salt-bridge
with Arg-19 of HicA (Fig. 2B). This movement breaks the Leu-
88–Phe-102 interaction between adjacent subunits in free
HicB.
The loss of these packing interactions allows the HicB C-do-
mains to rotate outward in HicAB (Fig. 3A) without any signif-
icant rearrangements within the C-terminal domains them-
selves (hydrophobic packing is 80% conserved within the
C-domains between HicB and HicAB). Residues from the
C-terminal helix (Arg-124 and Leu-127) formnew intrasubunit
interactions with residues Phe-59, Asp-84, Ser-86, and Gln-87
from the N-domain.
Analysis of the surface charge distribution for HicB revealed
a clustering of positive charge on each of the RHH C-domains
(Fig. 3B). In the free form the C-domains are oriented in such a
way as these clusters align to form an extended positively
charged patch.When viewed froma 90° rotated angle this patch
can be seen to encompass an obvious groove at its center. In the
HicAB structure, however, these domains reorient to move
these clusters of charges to opposite sides of the HicAB com-
plex, breaking the positively charged patch apart (Fig. 3C).
Small angle X-ray scattering (SAXS) was employed to con-
firm the solution structure ofHicB. The shape envelope ofHicB
fitted the crystal structure of the tetrameric form of HicB (Fig.
4A) (statistics given in Table S5, 2 1.98). These results con-
firm that HicB is a tetramer in solution. By contrast, the sym-
metrical HicB tetramer component from the HicAB complex
gave a poor fit (2 8.94, Fig. S5A) to this envelope. SAXS data
collected on the HicAB complex generated a shape envelope
that could accommodate the symmetrical HicB tetramer com-
ponent of theHicAB crystal structure (Fig. 4B, 2 2.89). Con-
versely, the reverse analysis showed that the HicB tetramer
could not be fitted to the SAXS shape envelope of the HicAB
complex (Fig. S5B, 2  8.06). These results support our crys-
tallographic data that the HicB to HicAB transition involves
substantial conformational changes in both the crystal and
solution forms.
HicB binds a symmetry DNAmotif in the hicAB operon
promoter region
Electrophoreticmobility shift assays (EMSA)were applied to
investigate whethermultimers of HicB or HicAB bound to syn-
thetic oligonucleotides upstream of hicAB (Fig. S6, A and B).
This revealed a binding region for HicB (S1–2) 17–36 bp
upstream of the start codon (Fig. 5A). This region contained a
single palindromic sequence containing two sites (S1 and S2)
spanning 24 to 19 (ACACA) and 34 to 29 (TGTGT).
HicB-NT lacking the C-terminal RHH domain did not bind
(Fig. S6C). Mutating nucleotides within the palindromic se-
quence fromACACA (S1) toAGGGA (MS1) orTGTGT (S2) to
TCCCT (MS2) also abolished binding of these oligonucleotides
to HicB (Fig. S6D).
Binding of fluorescently labeled S1–2 (HEX–S1–2) to HicB
was also measured using fluorescence anisotropy (FA) (Fig. 5B)
and the Kd determined to be 3.0  0.4 nM. We did not detect
binding of HicB-NT or HicA to DNA (Fig. S6, F and G).
Structure of HicAB
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In the presence of sub-stoichiometric ratios of HicA (HicA:
HicB 0.5:1) theKdwas broadly similar (1.9 0.2 nM) (Fig. 5C) to
the Kd of HicB alone. However, when the HicA:HicB ratio was
increased to greater than one (1.2:1), the titration did not reach
saturation and the Kdwas estimated to be in excess of0.4 M
(Fig. 5D).WhenHicAwas titrated into a preformed complex of
HicB–HEX–S1–2 (80% bound), we observed dissociation of
HicB from the DNA at HicA:HicB 1 (IC50  63.5  0.9 nM;
Hill coefficient  2.6) and full dissociation of the HicB–DNA
complex was observed after the addition of300 nMHicA (Fig.
5E). The dissociation curve showed a sigmoidal dependence on
the concentration of HicA indicative of a cooperative binding
mechanism. The presence of free DNA at excess HicA:HicB
ratios was also observed by EMSA (Fig. S6E).
The concentration of positively charged and polar groups on
the RHH C-terminal domains of HicB (Fig. 3B) suggested that
Figure 2. The HicAB heterooctameric complex. A, cartoon representation of the HicAB heterooctamer where HicA (red) binds to the N-terminal domain of
each HicB subunit (blue, pink, green, and yellow). B, HicA (red) has a triple stranded -sheet that interacts with the 1 helix of HicB (blue). C, the functionally
important residue His-24 (H24A in the crystal structure) is predicted to project into a polar pocket formed by Ser-27, Glu-41, and Asn-37 of HicB. D, cartoon
representation of new interaction sites across the HicB tetramer. Box 1 highlights the new internal hydrophobic network formed because of the rotation of
Leu-85 and Leu-88 to interact with Ile-22, Ile-43, Val-47, and Val-83 within subunit 1 of HicB (blue). Box 2 indicates new intersubunit interactions between
adjacent subunits (1 and3) ofHicB (blue andgreen). Pro-100 andPhe-102 formhydrophobic contacts to Ile-22, Ile-43, Val-47, Val-57, andVal-83,whereasGlu-58
interacts with Lys-106. Because of the symmetrical nature of HicB within the heterooctamer, these interactions sites are conserved between subunits of HicB.
This is highlighted for HicB subunit 2 (Boxes 3 and 4).
Structure of HicAB
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these residues might be involved in DNA binding. Purified HicB
variants with R94A, R94E, N96A, N96Q, S98A, and S98T muta-
tions were tetrameric and bound to HicA. Compared with WT
HicB, gel shift assays for R94A, R94E, N96A, and S98A all showed
loss of binding to S1–2DNA(Figs. S7 andS8).MutantsN96Qand
S98T both showed amarked reduction in binding (Fig. S8D).
Discussion
In this study we have solved the high-resolution X-ray struc-
tures of B. pseudomallei HicB and the complete complex of
HicAB. The PISA server (39) confirmed the HicB oligomeric
state (Table S6) and the dimerization interfaces within the
tetramer were specific to HicB family members, with minor
similarity to a putative RNA-binding protein (Table S7). DALI
(40) also calculated structural similarity with other HicB family
members, including putative antitoxin structures, but not non-
HicB type 2 antitoxins (Table S8). HicB resembled several
RNA-binding proteins and endoribonuclease/helicases, con-
sistent with the observation that HicB contains a partially
degraded RNase H fold and a DNA-binding domain (32). The
PISA server also confirmed the HicAB oligomeric state (Table
S9) and that the HicAB interface was specific to HicAB family
members (Table S10). Our model supports the previous find-
ings that Y. pestis HicB3 (33) binds to HicA3 and buries func-
tionally essential residues of the toxin (Fig. S9). This may indi-
cate a general mechanism for HicA recognition by HicB. A
recent study has reported the HicBA crystal structure from
Streptococcus pneumoniae and this also supports this mecha-
nism (41). Although this complex is also heterooctameric, the
authors did not observe the open conformation that we report
here.
Our work also provides new insight into HicB recognition of
DNA. The palindromic DNA binding sites (S1–2) we have
identified overlap with the predicted10 sequence and cAMP
receptor protein (CRP)–binding sites (Fig. 5). The DNA-bind-
ing sites we have identified are distinct from those previously
seen in studies with E. coli HicAB and show that HicB from
different species can recognize different DNA motifs. A single
promoter has been experimentally mapped to a similar
upstream region of hicA3B3 in Y. pestis. However, we cannot
exclude the possibility of a second promoter, as suggested
upstream of E. coli hicAB (37). We have shown that residues in
the RHHmotif (5) of the C-terminal domain (Arg-94, Asn-96,
and Ser-98), which form a contiguous positively charged patch
in the unbound conformation of HicB (Fig. 3B), are important
for DNA recognition. FA and EMSA experiments (Fig. 5 and
Fig. S6) reported similar results, although it was not possible
to quantify the unbound and bound DNA components in
EMSA because of the observed streaking of some HicB–DNA
complexes. The RHH motif is also present in DinJ, FitA, and
RelB antitoxins (29, 38, 42). A structural comparison revealed
direct conservation of the proximal basic residue of the strand
(Arg-94) and Asn-96. Arg-94, Asn-96, and Ser-98 have Lys-95,
Asn-97, and Thr-99 counterparts in HicB3 suggesting their
more general importance (Fig. S10).
The broad mechanism by which HicB binding to DNA is
modulated by HicA has been observed previously. EMSA data
show that an excess of E. coli HicA resulted in the dissociation
of E. coli HicB from DNA (37). In our distinct system, where
HicB contains a different DNA-binding motif, we observe a
similar phenomenon. We have, however, now elucidated at a
molecular level how sufficiently high concentrations of HicA
attenuate HicB:DNA interactions by stabilizing a rearranged
conformation of HicB that binds DNA weakly. Whereas the
free HicB tetramer contains two RHH domains that are ori-
ented to contact S1 and S2 sites of the palindromic DNA
sequence, the RHH domains are separated by 70 Å in the het-
erooctamer and cannotmake the necessary simultaneous inter-
actions with both S1 and S2 to achieve strong DNA binding.
Our structural and functional data and related functional
data for HicAB from E. coli and Y. pestis showed that HicA
binding decreased the affinity of HicB for DNA (37, 41). How-
Figure 3. Conformation rearrangements induced by HicA binding and
forming the complex HicAB. A, HicA (red) interacts with the1 helix of each
subunit of HicB (highlighted blue, pink, green, and yellow) in the unbound
conformation to form the heterooctameric HicAB complex (PDB ID: 6G26),
with5 strands of HicB also highlighted to illustrate their rotation upon com-
plexation. B, surface representation of HicB showing clustering of positive
charges on one face mapped to Arg-94, Asn-96, and Ser-98 of the C-terminal
domain of HicB. C, surface representation of HicAB highlighting perturbation
of thepositively chargedpatchof theC-terminal domain (Arg-94, Asn-96, and
Ser-98) because of rotation of the two RHH domains. HicA is represented as
gray to emphasize the surface charge of HicB.
Structure of HicAB
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ever, in the case of HicAB from S. pneumoniae (41) HicA
appeared to induce a modest increase of HicB:DNA-binding
affinity (Kd 8 M for HicB:DNA, 4 MHicAB:DNA) inferring
that HicA acts as a co-repressor rather than a de-repressor.
Because no free HicB structure has been reported for
S. pneumoniae (41), and the Y. pestisHicAB structure lacked
the C-terminal DNA-binding domains (33) (Fig. S9), the
conformational changes induced by HicA cannot be eluci-
dated. The two high-resolution structures presented herein
delineate the conformational changes in HicB that modulate
DNA binding.
Conditional cooperativity has been demonstrated in a num-
ber of systems where there are multiple antitoxin-binding sites
within the regulatory regions of DNA (15, 16, 20, 27, 28). Three
distinct molecular mechanisms have been proposed to explain
conditional cooperativity: steric exclusion between nonre-
pressing TA complexes; low–high affinity switches of toxin–
antitoxin interaction sites; and allosteric communication
between antitoxin domains (16). The RelBE systemoperates via
a steric exclusion mechanism where free toxin can compete
with a high-affinity toxin/antitoxin–DNA complex (Fig. 6A)
(24, 38). In contrast, in the Phd–Doc (15) (Fig. 6B) and CcdAB
(27) systems, when the antitoxin is in excess it binds both
high- and low-affinity sites on the toxin. However when the
toxin is in excess, only high-affinity–binding sites are occu-
pied by the antitoxin that results in conditional cooperativity
as the DNA–TA complex is disrupted. Phd (antitoxin) bind-
ing to the target operon is also allosterically regulated by the
toxin Doc by forming a more structured DNA-binding
domain upon association with sub-stoichiometric ratios of
Doc (15, 43).
The HicAB system described here falls into a class of TA
systems including DinJ–YafQ (29) (Fig. 6C) and MqsRA (30)
(Fig. 6D) where antitoxin binds to one or two operator sites but
these are not individually or cross-stabilized by toxin. Less is
known about the mechanism of de-repression or the fully de-
rerepressed state in these cases. In the DinJ–YafQ system, the
toxin YafQ has no influence on DinJ-binding affinity for DNA
and the mechanism for dissociation is currently unknown.
MqsRA on the other hand appears to operate under what has
been termed a simplified conditional cooperativitymodel. Here
the toxin is not a co-repressor but does act as a de-repressor,
therefore ensuring that excess toxin is still effectively countered
at the transcriptional level (16). The MqsRA operator contains
two palindromic regions, each ofwhich can independently bind
an MqsA dimer. There is however no stabilizing interaction
with MqsR and instead MqsR acts as a de-repressor because of
overlap of the MqsR and DNA-binding sites on MqsA (30). In
the case of HicAB, sub-stoichiometric levels of HicA have no
discernible effect on DNA binding. In contrast, an excess of
HicA causes dissociation of the HicB–DNA complex through a
large-scale conformational reorganization of HicB to form a
heterooctameric complex (Fig. 6E). The competitive mecha-
nism for DNA binding is similar to other related systems (30),
Figure4. Small angleX-ray scatteringofHicBandHicAB.A,ab initiomodelingof the crystal structure of the tetrameric formofHicB into the shape envelope
of HicB (white), with each subunit of HicB appropriately colored blue, pink, green, and yellow. The FoXS profile of the proposed scattering profile for the crystal
structure (red) against the experimental raw scattering data (black) is underneath (2 1.98). B, ab initiomodeling of the HicB component of the HicAB crystal
structure into the shape envelope of HicAB (white), with the corresponding FoXS profile underneath (2 2.89).
Structure of HicAB
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butwehave shownde-repression is cooperative at high concen-
trations of HicA. This allosteric regulation of interdomain
interactions has also been proposed as a mechanism for this
single-site conditional cooperativity but had not previously
been experimentally demonstrated (16). Although the struc-
tures defining the two end points of this process (i.e. HicB in
forms that are and are not competent to bind DNA) have been
determined here, further intermediate states are likely to exist.
Wehave for example observedHicA1–HicB4 andHicA2–HicB4
complexes by nativeMS (Fig. S4) and theY. pestisHicA2–HicB4
complex has previously been observed by size exclusion chro-
matography (SEC) multi-angle light scattering (33). Under
experimental conditions, the FA data indicate that HicB can
bind two HicA molecules with little change in the affinity of
HicB for DNA (Fig. 6E). Therefore, in the presence of DNA, the
population of free HicA2HicB4 in the open non-DNA–binding
form is low. However, in accordance with a previous study with
E. coliHicAB, competition experimentsmonitored with EMSA
were unable to confirm formation of a stable DNA–HicB4–
HicA1/2 complex (37). When HicB is in an open conformation,
four molecules of HicA can be accommodated. In this confor-
mation the DNA-binding sites are separated and cannot coop-
Figure 5.OverviewofHicBbinding to S1–2.A, overviewof the hicABoperon. The palindromic regionwithin the upstream region of hicAB that bindsHicB. S1
and S2 are highlighted in red and blue. CRP, cAMP receptor protein. B, quantification of HicB binding to HEX–S1–2. Samples contained 7.5 nM HEX–S1–2 in
DNA-binding buffer. The proportion of HEX–S1–2 bound by increasing concentration of HicBwas followed (n 1). Data of three independent repeats were fit
to Equation 2. C, quantification of HicA/HicB binding to HEX–S1–2 (n  1) at HicA:B 0.5:1. Again three repeats were fit to Equation 2. D, quantification of
HEX–S1–2binding toHicAB at 1.2:1 for three independent repeats (n1). Datawere fit to Equation 2. E, quantificationofHicAbinding to apreformed complex
ofHicBM (40nM)withHEX–S1–2 (7.5nM) corresponding to80%bound,HicB refers to themonomer concentrationofHicB. Theproportionof substratedisplaced
by increasing concentrations of HicA was calculated for three independent repeats via Equation 3 with a Hill coefficient of 2.6. For each experiment themean
value is plotted with error bars representing the S.E. Standard errors of Kd values were calculated in GraphPad Prism.
Structure of HicAB
J. Biol. Chem. (2018) 293(50) 19429–19440 19435
 at U
N
IV
 O
F EX
ETER on D
ecem
ber 17, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
eratively bind the target. Consequently, theKd forHicB binding
to DNA increases from 3 nM to 0.4 M. Whether the HicB
promoter site is occupied by HicB or not will be influenced by
the balance of two effects: the affinity of the closed formofHicB
to DNA versus the affinity/competition of HicA for HicB that
stabilizes the open, non-DNA–binding form. Within the cell
the interplay between HicB, DNA, and HicA interactions will
be complex. In a typical bacterium, the DNA target is at an
Figure 6. Overview of de-repressionmodels for RelBE, Phd–Doc, DinJ–YafQ,MqsRA, andHicAB. The toxin is highlighted in red and the antitoxin in blue,
whereas DNA-binding sites are represented by half arrows. A, the RelB2 dimer or RelB2E complex can bind to one of the two adjacent DNA operator sites, but
it is proposed that the formationof aW-shapedheterohexameric complex (RelB2E)2mayoccupybothadjacentDNAoperator sites simultaneously to confer full
transcriptional repression of the relBE operon. Excess toxin (RelE) binds a second site of a RelB dimer forming a rigid RelB2E2 heterotetramer, two heterote-
tramers that cannot simultaneously bind both operator sites because of steric hindrance resulting in transcriptional de-repression. Transcription of the relBE
operon returns RelB and RelE to stoichiometric levels ( 1:1). B, Doc forms a heteropentameric complex with Phd (Phd2-Doc-Phd2) by binding to Phd2 via low
(L) and high (H) affinity sites to confer full repression of the phd-doc operon by binding two operator sites. Doc allosterically regulates Phd to form a structured
DNA-binding domain to ensure full transcription repression only occurs upon formation of a Phd–Doc complex. An excess of Doc preferentially binds Phd
solely through H sites resulting in the formation of a rigid heterotetramer (Doc-Phd2-Doc) that cannot occupy both operator sites because of steric clashes
between adjacent heterotetramers.C andD, in contrast bothDinJ–YafQ (C) andMqsRA (D) do not follow themodel of conditional cooperativity, as both toxins
act as de-repressors rather than co-repressors. C, DinJ2 fully represses its operator via a single palindromic site. Addition of YafQ forms a YafQ-DinJ2-YafQ
heterotetrameric complex, but an excess does not result in de-repression of the DinJ/YafQ–DNA complex and the de-repression mechanism is unknown. D,
likewise,MqsA fully represses in the absenceofMqsR. ExcessMqsR competeswith anoverlappingDNA-binding site ofMqsA (highlighted in red) and formation
of a proposed heterotetramericMqsRA complex results in de-repression (the publishedMqsRA complex is a partial model). MqsA cannot simultaneously bind
bothMqsA and DNA. E, like MqsA and DinJ, HicB alone results in saturation of the palindromic sequences (S1–2). HicA binds the surface exposed 1 helices of
subunit 2 and 3 to form an intermediate HicA2HicB complex that does not result in an increase of affinity to S1–2. At concentrations of HicAHicB, there is
binding of a further twoHicAmolecules that results in the 90° rotation of the ribbon-helix-helixmotifs andprevents binding to the palindromic sequences and
dissociationofHicB fromDNA. The intermediate stepsof this pathwayareunknownandeither route, or anequilibriumbetween the two, cannotbediscounted
as of present.
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effective concentration of1–2 nM (44) and on the order of the
HicB–DNA dissociation constant (3 nM). At the point at which
the pool of free HicB has been largely bound as heterooctamers
by HicA and approaches the concentration of DNA, a mixture
of spontaneous dissociation and HicA-driven dissociation may
operate. Further studies are required to determine the series of
steps leading to the release of the final HicB molecule from
DNA in the presence of increasing concentrations of HicA.
Experimental procedures
Protein expression, purification, andmutation
All primers are given in Table S11. hicB (B. pseudomallei)
was cloned fromK96243 genomicDNAwithHicB_FL primer 1
and 2 and subcloned into pOPINE vector (pOPINE–HicB_FL)
before transformation into E. coli T7 Express cells. Cultures
were grown to OD 0.6 in LB media (37 °C) and induced (0.3
mM isopropyl -D-1-thiogalactopyranoside) at 16 °C (16 h).
Harvested cells were sonicated (50 mM Tris-HCl, 0.5 M NaCl,
10% (v/v) glycerol, pH 8.0) and purified by immobilized metal
affinity chromatography (IMAC) and SEC (HiLoad Superdex
75, 25 mM Tris-HCl, 150 mM NaCl, pH 7.5) (Fig. S1, E and F).
Secondary structure calculations predicted a stretch of disor-
dered amino acids at the C terminus and a construct lacking
135VRHA138was designed (HicB) aswell as a construct contain-
ing only the N-terminal residues (1–85) (HicB-NT) and both
were amplified from K96243 genomic DNA using appropriate
primers and subcloned into pOPINE (pOPINE–HicB and
pOPINE–HicB-NT). The pOPINE–HicB plasmid was used to
generate HicB_DM using mutagenic primers I51M and I99M.
HicB R94A, N96A, S98A, and N96Q genes were synthesized
(Thermo Scientific), cloned into pOPINE, and also used to sub-
sequently generate R94E and S98T. pOPINE–HicB_DM was
transformed into E. coli B834 and cultures grown in Seleno-
Methionine Nutrient Base supplemented with SelenoMethionine
Nutrient Mix and 40 mg/L selenomethionine (Molecular
Dimensions) at 37 °C to OD  0.6, followed by addition of 20
mg/L selenomethionine and induction (isopropyl -D-1-thio-
galactopyranoside 0.3 mM, 16 h, 25 °C). Purification buffers
were supplemented with 2 mM TCEP.
TheHicA (H24A)B. pseudomalleimutant bearing anN-termi-
nalHis6-tag and a tobacco etch virus cleavage site (ENLYFQ) con-
struct was generated by Thermo Fisher and subcloned into a
pET151-D/TOPO plasmid andHicA expressed and purified (36).
Crystallization and data collection
Crystallization conditions for HicB, HicB_DM, HicB-NT,
and HicAB are given in Table S2. Diffraction data were
recorded from cryo-cooled crystals (100 K) at the Diamond
Light Source Synchrotron in Oxford (i03 and i04). Data were
processed and integrated using XDS (45), Xia2 (46) and further
analyzed using Phenix (47).
Structure determination and refinement
HicB_FL crystals diffracted to 4 Å despite optimization.
Crystals of HicB diffracted to 1.8 Å but could not be solved
usingMR. HicB_DMdiffracted to 3 Å and a partial structure of
the P212121 crystal of selenomethionine incorporated HicB–
I51M/I99M was determined by single-wavelength anomalous
diffraction. Identification of heavy atoms sites, the resulting
phase calculations, and building of an initial model were deter-
mined by Crank2 (48), REFMAC5 (49), and Buccaneer (50).
Iterative rounds ofmanualmodel building and refinementwere
carried out using Phenix andCoot (51). HicB-NT (P212121) was
solved via MR and the Autobuild Pipeline in Phenix (52) using
the partial model derived from HicB_DM followed by manual
refinement using Coot and REFMAC.
The structure of HicB (P41) was determined by MR (Phaser)
using the HicB_NT structure and C-terminal domains were
manually built. The HicB model comprises 1–131 residues of
the native sequence.
The structure of HicAB was also solved via MR. MOLREP
(53) identified high-contrast solutions for the two C-domain
dimers with rotation peaks 1 (5.74) and 5 (4.45). Fixing the
C-domains allowed four N-domains of HicB to be located
when 200 rotation peaks were used in the translation search
(MOLREP option NP  200). The four correct rotation peaks
were 5, 10, 162, and 4 in the list. Four copies of a single chain of
HicA (PDB ID: 4C26) were positioned into the resulting elec-
tron density using the spherically averaged phased translation
function (54) and phased translation function implemented in
MOLREP. The 4-fold NCS averaging in DM (55) was used for
phase improvement of HicAB structure with masks and NCS
operators calculated separately forHicAandeachdomainofHicB.
Densitymodification phases were input for phase refinement (56)
inREFMAC5 (49). Resulting electron densitymaps allowed build-
ing of the hinge regions of HicBmonomers in Coot.
Mass spectrometry
For native electrospray ionization (ESI) MS, 20 M samples
ofHicBwere dialyzed in 100mM ammonium acetate. Nano-ESI
experiments were performed on a Synapt G2-Si (Waters) using
acquisition parameters adapted from Ref. 57. Complexes of
HicAB were formed by mixing appropriate ratios of HicA
and HicB, then dialyzed in 100 mM NH4Cl, and analyzed as
described for HicB.
Analytical size exclusion chromatography
HicAB was pre-formed at 50 M and incubated at 25 °C (1 h)
and analyzed with a calibrated (58) Superdex 75 10/300 GL
pre-packed column (Table S12).
Small angle X-ray scattering
In line SEC-SAXS for HicB and HicAB were collected at
Beamline 21, Diamond Light Source, using an Agilent 1200
HPLC and 2.4 ml Superdex S200 column (Table S5). 50 l of
protein at an appropriate concentration was loaded (0.04
ml/min) onto an equilibrated S200 column (25 mM Tris-HCl,
150 mM NaCl, pH 7.5). Frames were collected at 3 s per frame,
25 °C. X-ray scattering was recorded (Pilatus 2Mdetector) with
a fixed camera length of 4.014 m, at 12.4 keV. Angular range q
data were collected between 0.006 and 0.042 Å1. ScÅtter
(www.bioisis.net)4 (68) determined the radius of gyration (Rg),
4 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
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the maximum particle dimension (Dmax), and the pair distribu-
tion function (P(r)) (59, 60). Ab initio bead density shape enve-
lope models for HicB and HicAB were generated by DAMMIF
(61), averaging 23 independent runs using the program
DAMAVER, before a single DAMMIN run refinement (62).Ab
initio bead density shape envelopemodels were aligned to both
ab initio models and crystal structures using SUPCOMB (63).
FoXS (64) was used to compare the calculated X-ray scattering
of crystal structures with the experimental scattering profile of
each protein. Experimental SAXS data and derived models of
both HicB and HicAB have been deposited in the Small Angle
Scattering Biological Data Bank (SASBDB) (65) with the acces-
sion codes SASDD45 and SASDD55.
DNA-binding assays
Gel shift assays were carried out with specific annealed pairs
of oligonucleotides (Integrated DNA Technologies) and serial
dilutions of protein. For determination of the DNA-binding
region, 12.8 M HicBM (3.2 M tetramer concentration) was
equilibrated at room temperature with 3MDNA for 30min in
25 mM Tris, 100 mM NaCl, 10% glycerol; loaded onto a 10%
Tris-acetate-EDTAgel (66) in 1TAEbuffer; run at 100V (1 h,
16 °C); and de-stained in ethidium bromide in 1 TAE buffer.
For stepwise binding between the 0–20 and 0–40 fragments,
the mixture was loaded onto a 15% TAE gel. For all other gel-
shift assays, serial dilutions of HicB and appropriate constructs
(0.8–3.2 M) were equilibrated (25 °C) with 2 M 17–36
dsDNA (S1–2) (30 min) before loading onto a 10% TAE gel.
HicA depression of HicB.S1–2 complex involved challenging a
mixture of tetrameric HicB (3.2 M) bound to S1–2 DNA
(2 M) with increasing concentrations of HicA (0.8–50.8 M).
Fluorescence anisotropy
Fluorescence equilibrium titrations were performed (Jobin
Yvon Fluorolog, Horiba Scientific) to determine the dissocia-
tion constants (Kd) for HicB, HicAB, HicA, and HicB-NT bind-
ing at 20 °C to S1–2 (5	-ATGTGTATAATTACACACAA-3	)
which harbored the fluorescence dye HEX at the 5	-end (7.5
nM). The excitationwavelengthwas set at 530 nm and the emis-
sion intensity set at 554 nm. Slit widths were set to 5.0 nm for
both excitation and emission. Following sample equilibration
for 2 min, three data points with an integration time of 0.5 s
were collected for each titration point. Anisotropy was deter-
mined by Equation 1.
r 
I II I
Itot

III I
III	 2I
(Eq. 1)
Titrationswere performed in 25mMTris-HCl, 100mMNaCl,
pH7.5, in a total volumeof 200l in a 10 2mmquartz cuvette
(Hellma Analytics). HicB, HicAB, and HicB-NT were titrated
into HEX–S1–2 up to 150 nM. HicA was titrated until an end
point of 1000 nM. For competition assays, a preformed HicB
(40 nM)–S1–2 (7.5 nM) complex (80% bound) (67) was formed
before the addition of HicA to a final concentration of 300 nM.
Data fitting
Data were fitted to a single-component binding equation to
determine the dissociation binding constant Kd using GraphPad
Prism 7.04, as in Equation 2.
Y  AD	 
ADP AD

 X	 Kd	 n 
X	 n	 Kd2 
4Xn2n  (Eq. 2)
Where ADP is the anisotropy of the fully bound HicB–S1–2
complex, AD is the anisotropy of unbound S1–2, n is the stoi-
chiometry and [X] is the concentration of protein. For compe-
tition assays involving HicA, data were fitted to a four-compo-
nent inhibition equation to determine the IC50 value via
Equation 3.
A  AD	

ADP AD
1	
HAH
IC50
H
(Eq. 3)
Where A is the measured anisotropy, AD is the anisotropy of
free S1–2, ADP is the anisotropy of the saturated HicB–S1–2
complex, [HA] is the concentration of HicA,H is the Hill slope.
The atomic coordinates of HicB-NT, HicB, and the HicAB
complex have been deposited to the Protein Data Bank under
accession codes: PDB IDs 6G1C, 6G1N, and 6G26, respectively.
Experimental SAXS intensities of HicB and HicAB are depos-
ited in SASBDB database (accession entries SASDD45 and
SASDD55).
Author contributions—A. J. W., R. W. T., and M. P. C. conceptual-
ization; A. J. W. data curation; A. J. W., C. W., M. N. I., and M. S. D.
formal analysis; A. J. W., M. N. I., H. C., M. G., P. M., O. J. W.,
N. J. H., and M. P. C. investigation; A. J. W., N. J. H., R. W. T., and
M. P. C. writing-original draft; A. J. W., C. W., R. W. T., andM. P. C.
writing-review and editing; M. S. D., R. W. T., and M. P. C. method-
ology; R. W. T. and M. P. C. funding acquisition; M. P. C. supervi-
sion; M. P. C. project administration.
References
1. Hall, A. M. J., Gollan, B., and Helaine, S. (2017) Toxin-antitoxin systems:
Reversible toxicity. Curr. Opin. Microbiol. 36, 102–110 CrossRef Medline
2. Page, R., and Peti, W. (2016) Toxin-antitoxin systems in bacterial growth
arrest and persistence. Nat. Chem. Biol. 12, 208–214 CrossRef Medline
3. Lobato-Ma´rquez, D., Díaz-Orejas, R., and García-Del Portillo, F. (2016)
Toxin-antitoxins and bacterial virulence. FEMS Microbiol. Rev. 40,
592–609 CrossRef Medline
4. Lewis, K. (2010) Persister cells. Annu. Rev. Microbiol. 64, 357–372
CrossRef Medline
5. Gerdes, K., and Maisonneuve, E. (2012) Bacterial persistence and toxin-
antitoxin loci. Annu. Rev. Microbiol. 66, 103–123 CrossRef Medline
6. Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., and Leibler, S. (2004)
Bacterial persistence as a phenotypic switch. Science 305, 1622–1625
CrossRef Medline
7. Goormaghtigh, F., Fraikin, N., Putrinsˇ, M., Halleart, T., Hauryliuk, V.,
Garcia-Pino, A., Sjo¨din, A., Kasvandik, S., Udekwu, K., Tenson, T., Kaladu
N., and Van Melderen, L. (2018) Reassessing the role of type II toxin-
antitoxin systems in formation of Escherichia coli type II persister cells.
MBio 9, e00640-18 CrossRef Medline
Structure of HicAB
19438 J. Biol. Chem. (2018) 293(50) 19429–19440
 at U
N
IV
 O
F EX
ETER on D
ecem
ber 17, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
8. Harms, A., Maisonneuve, E., and Gerdes, K. (2016) Mechanisms of bacte-
rial persistence during stress and antibiotic exposure. Science 354, aaf4268
CrossRef Medline
9. Song, S., and Wood, T. K. (2018) Post-segregational killing and phage
inhibition are notmediated by cell death through toxin/antitoxin systems.
Front. Microbiol. 9, 814 CrossRef Medline
10. Lee, K. Y., and Lee, B. J. (2016) Structure, biology, and therapeutic appli-
cation of toxin-antitoxin systems in pathogenic bacteria. Toxins 8, E305
CrossRef Medline
11. Cheverton, A.M., Gollan, B., Przydacz,M.,Wong, C. T.,Mylona, A., Hare,
S. A., and Helaine, S. (2016) A salmonella toxin promotes persister forma-
tion through acetylation of tRNA.Mol. Cell 63, 86–96 CrossRef Medline
12. Harms, A., Brodersen, D. E., Mitarai, N., and Gerdes, K. (2018) Toxin,
targets and triggers: An overview of toxin-antitoxin biology.Mol. Cell 70,
768–784 CrossRef Medline
13. Ke˛dzierska, B., and Hayes, F. (2016) Emerging roles of toxin-antitoxin
modules in bacterial pathogenesis.Molecules 21, E790 CrossRef Medline
14. Muthuramalingam, M., White, J. C., and Bourne, C. R. (2016) Toxin-
antitoxin modules are pliable switches activated by multiple protease
pathways. Toxins 8, E214 CrossRef Medline
15. Garcia-Pino, A., Balasubramanian, S., Wyns, L., Gazit, E., De Greve, H.,
Magnuson, R. D., Charlier, D., van Nuland, N. A. J., and Loris, R. (2010)
Allostery and intrinsic disorder mediate transcription regulation by con-
ditional cooperativity. Cell 142, 101–111 CrossRef Medline
16. Loris, R., and Garcia-Pino, A. (2014) Disorder- and dynamics-based
regulatory mechanisms in toxin-antitoxin modules. Chem. Rev. 114,
6933–6947 CrossRef Medline
17. Afif, H., Allali, N., Couturier, M., and Van Melderen, L. (2001) The ratio
between CcdA and CcdB modulates the transcriptional repression of the
ccd poison-antidote system.Mol. Microbiol. 41, 73–82 CrossRefMedline
18. Wilbur, J. S., Chivers, P. T.,Mattison, K., Potter, L., Brennan, R. G., and So,
M. (2005) Neisseria gonorrhoeae FitA interacts with FitB to bind DNA
through its ribbon-helix-helix motif. Biochemistry 44, 12515–12524
CrossRef Medline
19. Zorzini, V., Buts, L., Sleutel, M., Garcia-Pino, A., Talavera, A., Haesaerts,
S., De Greve, H., Cheung, A., van Nuland, N. A. J., and Loris, R. (2014)
Structural and biophysical characterization of Staphylococcus aureus Sa-
MazF shows conservation of functional dynamics. Nucleic Acids Res. 42,
6709–6725 CrossRef Medline
20. Monti, M. C., Herna´ndez-Arriaga, A. M., Kamphuis, M. B., Lo´pez-Vil-
larejo, J., Heck, A. J. R., Boelens, R., Díaz-Orejas, R., and van den Heuvel,
R. H. H. (2007) Interactions of kid-kis toxin-antitoxin complexes with the
parD operator-promoter region of plasmid R1 are piloted by the Kis anti-
toxin and tuned by the stoichiometry of kid-kis oligomers. Nucleic Acids
Res. 35, 1737–1749 CrossRef Medline
21. Khoo, S. K., Loll, B., Chan,W. T., Shoeman, R. L., Ngoo, L., Yeo, C. C., and
Meinhart, A. (2007) Molecular and structural characterization of the
PezAT chromosomal toxin-antitoxin system of the human pathogen
Streptococcus pneumoniae. J. Biol. Chem. 282, 19606–19618 CrossRef
Medline
22. Johnson, E. P., Strom, A. R., and Helinski, D. R. (1996) Plasmid RK2 toxin
protein ParE: Purification and interactionwith the ParD antitoxin protein.
J. Bacteriol. 178, 1420–1429 CrossRef Medline
23. Magnuson, R., and Yarmolinsky, M. B. (1998) Corepression of the P1
addiction operon by Phd and Doc. J. Bacteriol. 180, 6342–6351 Medline
24. Overgaard,M., Borch, J., Jørgensen,M. G., and Gerdes, K. (2008)Messen-
ger RNA interferase RelE controls relBE transcription by conditional co-
operativity.Mol. Microbiol. 69, 841–857 CrossRef Medline
25. Mate´, M. J., Vincentelli, R., Foos, N., Raoult, D., Cambillau, C., and Ortiz-
Lombardía, M. (2012) Crystal structure of the DNA-bound VapBC2 anti-
toxin/toxin pair from Rickettsia felis. Nucleic Acids Res. 40, 3245–3258
CrossRef Medline
26. Ke¸dzierska, B., Lian, L. Y., andHayes, F. (2007)Toxin-antitoxin regulation:
Bimodal interaction of YefM-YoeB with paired DNA palindromes exerts
transcriptional autorepression. Nucleic Acids Res. 35, 325–339 CrossRef
Medline
27. De Jonge, N., Garcia-Pino, A., Buts, L., Haesaerts, S., Charlier, D., Zangger,
K., Wyns, L., De Greve, H., and Loris, R. (2009) Rejuvenation of CcdB-
poisoned gyrase by an intrinsically disordered protein domain. Mol. Cell
35, 154–163 CrossRef Medline
28. Winther, K. S., and Gerdes, K. (2012) Regulation of enteric vapBC tran-
scription: Induction by VapC toxin dimer-breaking.Nucleic Acids Res. 40,
4347–4357 CrossRef Medline
29. Ruangprasert, A., Maehigashi, T., Miles, S. J., Giridharan, N., Liu, J. X.,
and Dunham, C. M. (2014) Mechanisms of toxin inhibition and tran-
scriptional repression by Escherichia coli DinJ-YafQ. J. Biol. Chem.
289, 20559–20569 CrossRef Medline
30. Brown, B. L., Lord, D. M., Grigoriu, S., Peti, W., and Page, R. (2013) The
Escherichia coli toxin MqsR destabilizes the transcriptional repression
complex formed between the antitoxin MqsA and the mqsRA operon
promoter. J. Biol. Chem. 282, 1286–1294 CrossRef Medline
31. Jørgensen, M. G., Pandey, D. P., Jaskolska, M., and Gerdes, K. (2009) HicA
of Escherichia coli defines a novel family of translation-independent
mRNA interferases in bacteria and archaea. J. Bacteriol. 191, 1191–1199
CrossRef Medline
32. Makarova, K. S., Grishin, N. V., and Koonin, E. V. (2006) The HicAB
cassette, a putative novel, RNA-targeting toxin-antitoxin system in ar-
chaea and bacteria. Bioinformatics 22, 2581–2584 CrossRef Medline
33. Bibi-Triki, S., de la Sierra-Gallay, I., Lazar,N., Leroy, A., VanTilbeurgh,H.,
Sebbane, F., and Pradel, E. (2014) Functional and structural analysis of
HicA3-B3, a novel toxin-antitoxin system of Yersinia pestis. J. Bacteriol.
196, 3712–3723 CrossRef Medline
34. Limmathurotsakul, D., Golding, N., Dance, D. A. B., Messina, J. P., Pigott,
D. M., Moyes, C. L., Rolim, D. B., Bertherat, E., Day, N. P. J., Peacock, S. J.,
and Hay, S. I. (2016) Predicted global distribution of Burkholderia pseu-
domallei and burden of melioidosis. Nat. Microbiol. 1, 1–5 CrossRef
Medline
35. Lewis, E. R.G., andTorres, A.G. (2016) The art of persistence—the secrets
to Burkholderia chronic infections. Pathog. Dis. 74, ftw070 CrossRef
Medline
36. Butt, A., Higman, V. A., Williams, C., Crump, M. P., Hemsley, C. M.,
Harmer, N., and Titball, R. W. (2014) The HicA toxin from Burkholderia
pseudomallei has a role in persister cell formation. Biochem. J. 459,
333–344 CrossRef Medline
37. Turnbull, K. J., and Gerdes, K. (2017) HicA toxin of Escherichia coli dere-
presses hicAB transcription to selectively produce HicB antitoxin. Mol.
Microbiol. 104, 781–792 CrossRef Medline
38. Bøggild, A., Sofos, N., Andersen, K. R., Feddersen, A., Easter, A. D., Pass-
more, L. A., and Brodersen, D. E. (2012) The crystal structure of the intact
E. coli ReIBE toxin-antitoxin complex provides the structural basis for
conditional cooperativity. Structure 20, 1641–1648 CrossRef Medline
39. Krissinel, E., and Henrick, K. (2007) Inference of macromolecular assem-
blies from crystalline state. J. Mol. Biol. 372, 774–797 CrossRef Medline
40. Holm, L., and Laakso, L. M. (2016) Dali server update. Nucleic Acids Res.
44,W351–W355 CrossRef Medline
41. Kim, D. H., Kang, S. M., Park, S. J., Jin, C., Yoon, H. J., and Lee, B. J. (2018)
Functional insights into the Streptococcus pneumoniaeHicBA toxin-anti-
toxin system based on a structural study. Nucleic Acids Res. 46,
6371–6386 CrossRef Medline
42. Mattison, K., Wilbur, J. S., So, M., and Brennan, R. G. (2006) Structure of
FitAB from Neisseria gonorrhoeae bound to DNA reveals a tetramer of
toxin-antitoxin heterodimers containing pin domains and ribbon-helix-
helix motifs. J. Biol. Chem. 281, 37942–37951 CrossRef Medline
43. Garcia-Pino, A., De Gieter, S., Talavera, A., De Greve, H., Efremov, R. G.,
and Loris, R. (2016) An intrinsically disordered entropic switch deter-
mines allostery in Phd-Doc regulation. Nat. Chem. Biol. 12, 490–496
CrossRef Medline
44. Milo, R. (2013) What is the total number of protein molecules per cell
volume?A call to rethink some published values.Bioessays 35, 1050–1055
CrossRef Medline
45. Kabsch,W. (2010) XDS.Acta Crystallogr. D Biol. Crystallogr. 66, 125–132
CrossRef Medline
46. Winter, G. (2010) xia2: An expert system for macromolecular crystallog-
raphy data reduction. J. Appl. Cryst. 43, 186–190 CrossRef
47. Adams, P.D., Afonine, P. V., Bunko´czi, G., Chen,V. B., Davis, I.W., Echols,
N., Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, R. W., Mc-
Structure of HicAB
J. Biol. Chem. (2018) 293(50) 19429–19440 19439
 at U
N
IV
 O
F EX
ETER on D
ecem
ber 17, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Coy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C.,
Richardson, J. S., Terwilliger, T. C., and Zwart, P. H. (2010) PHENIX: A
comprehensive Python-based system for macromolecular structure solu-
tion. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 CrossRef Medline
48. Skuba´k, P., and Pannu, N. S. (2013) Automatic protein structure solution
from weak X-ray data. Nat. Commun. 4, 2077 CrossRef Medline
49. Murshudov, G. N., Skuba´k, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A.,
Nicholls, R. A., Winn, M. D., Long, F., and Vagin, A. A. (2011) REFMAC5
for the refinement of macromolecular crystal structures.Acta Crystallogr.
D Biol. Crystallogr. 67, 355–367 CrossRef Medline
50. Cowtan, K. (2006) The Buccaneer software for automated model build-
ing. 1. Tracing protein chains. Acta Crystallogr. D Biol. Crystallogr. 62,
1002–1011 CrossRef Medline
51. Emsley, P., and Cowtan, K. (2004) Coot: Model-building tools for molec-
ular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132
CrossRef Medline
52. Terwilliger, T. C., Grosse-Kunstleve, R. W., Afonine, P. V., Moriarty,
N. W., Zwart, P. H., Hung, L. W., Read, R. J., and Adams, P. D. (2008)
Iterative model building, structure refinement and density modification
with the PHENIX AutoBuild wizard. Acta Crystallogr. D Biol. Crystallogr.
64, 61–69 CrossRef Medline
53. Vagin, A., and Teplyakov, A. (2010) Molecular replacement with
MOLREP. Acta Crystallogr. D Biol. Crystallogr. 66, 22–25 CrossRef
Medline
54. Vagin, A. A., and Isupov, M. N. (2001) Spherically averaged phased trans-
lation function and its application to the search for molecules and frag-
ments in electron-density maps. Acta Crystallogr. D Biol. Crystallogr. 57,
1451–1456 CrossRef Medline
55. Cowtan, K. (2010) Recent developments in classical density modification.
Acta Crystallogr. D Biol. Crystallogr. 66, 470–478 CrossRef Medline
56. Pannu, N. S., Murshudov, G. N., Dodson, E. J., and Read, R. J. (1998)
Incorporation of prior phase information strengthens maximum-likeli-
hood structure refinement. Acta Crystallogr. D Biol. Crystallogr. 54,
1285–1294 Medline
57. Wen, Y. R., Sobott, F., and Devreese, B. (2016) ATP and autophosphory-
lation driven conformational changes of HipA kinase revealed by ion mo-
bility and crosslinking mass spectrometry. Anal. Bioanal. Chem. 408,
5925–5933 CrossRef Medline
58. Tayyab, S., Qamar, S., and Islam, M. (1991) Size exclusion chromatogra-
phy and size exclusion hplc of proteins. Biochem. Educ. 19, 149–152
CrossRef
59. Glatter, O. (1977) A new method for evaluation of small-angle scattering
data. J. Appl. Crystallogr. 10, 415–421 CrossRef
60. Svergun, D. I. (1992) Determination of the regularization parameter in
indirect-transformmethods using perceptual criteria. J. Appl. Crystallogr.
25, 495–503 CrossRef
61. Franke, D., and Svergun, D. I. (2009) DAMMIF, a program for rapid ab-
initio shape determination in small-angle scattering. J. Appl. Crystallogr.
42, 342–346 CrossRef Medline
62. Volkov, V. V., and Svergun, D. I. (2003) Uniqueness of ab initio shape
determination in small-angle scattering. J. Appl. Crystallogr. 36, 860–864
CrossRef
63. Kozin, M. B., and Svergun, D. I. (2001) Automated matching of high- and
low-resolution structural models. J. Appl. Crystallogr. 34, 33–41 CrossRef
64. Schneidman-Duhovny, D., Hammel, M., Tainer, J. A., and Sali, A. (2013)
Accurate SAXS profile computation and its assessment by contrast vari-
ation experiments. Biophys. J. 105, 962–974 CrossRef Medline
65. Valentini, E., Kikhney, A. G., Previtali, G., Jeffries, C.M., and Svergun, D. I.
(2015) SASBDB, a repository for biological small-angle scattering data.
Nucleic Acids Res. 43, D357–D363 CrossRef Medline
66. Hellman, L. M., and Fried, M. G. (2007) Electrophoretic mobility shift
assay (EMSA) for detecting protein-nucleic acid interactions.Nat. Protoc.
2, 1849–1861 CrossRef Medline
67. Huang, X. Y. (2003) Fluorescence polarization competition assay: The
range of resolvable inhibitor potency is limited by the affinity of the fluo-
rescent ligand. J. Biomol. Screen. 8, 34–38 CrossRef Medline
68. Rambo, R. P., and Tainer, J. A. (2013) Accurate assessment of mass,
models and resolution by small-angle scattering.Nature 496, 477–481
CrossRef Medline
Structure of HicAB
19440 J. Biol. Chem. (2018) 293(50) 19429–19440
 at U
N
IV
 O
F EX
ETER on D
ecem
ber 17, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Richard W. Titball and Matthew P. Crump
Gromova, Philip Marsh, Oliver J. Wilkinson, Mark S. Dillingham, Nicholas J. Harmer, 
Ashley J. Winter, Christopher Williams, Michail N. Isupov, Hannah Crocker, Mariya
antitoxin HicB to DNA
dependent binding of the protein−The molecular basis of protein toxin HicA
doi: 10.1074/jbc.RA118.005173 originally published online October 18, 2018
2018, 293:19429-19440.J. Biol. Chem. 
  
 10.1074/jbc.RA118.005173Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/293/50/19429.full.html#ref-list-1
This article cites 68 references, 10 of which can be accessed free at
 at U
N
IV
 O
F EX
ETER on D
ecem
ber 17, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
